Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
Is a |
ekspektorans |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
Is a |
Product containing hydrocodone (medicinal product) |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocodone (substance) |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Expectorant agent (substance) |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
Is a |
hydrocodonhydrogentartrat + kaliumguaiacolsulfonat |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocodone bitartrate |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Potassium guaiacolsulfonate |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
Has manufactured dose form |
oral væske |
false |
Inferred relationship |
Some |
|
|
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Some |
|
|